To determine whether excess OX activity is necessary for developing hypertension during development, we evaluated the effects of eliminating some OX–neurons via Hcrt–SAP injection into the hypothalamus on MAP and ventilatory hypercapnic chemoreflex in SHRs during a developmental period (Figures 4, 5). This evidence concerns the gene HCRT and hypertensive disorder.